Development of 11β-HSD1 inhibitors for the treatment of type 2 diabetes

被引：31
|
作者：
Hale, Clarence [1 ]
Wang, Minghan [1 ]
机构：
[1] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2008年 / 8卷 / 07期
关键词：
11 beta-hydroxysteroid dehydrogenase; glucocorticoid receptor; cortisol; ex vivo activity; insulin resistance; Cushing's syndrome;
D O I：
10.2174/138955708784567421
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Glucocorticoid action is linked to the development of obesity and insulin resistance. Inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) has been proposed as a strategy to suppress glucocorticoid action in a tissue-specific manner. A large variety of 11 beta-HSD1 inhibitor classes are under investigation by the pharmaceutical industry to treat type 2 diabetes and obesity.
引用
收藏
页码：702 / 710
页数：9
相关论文
共 50 条
  • [21] Discovery of orally active butyrolactam 11β-HSD1 inhibitors
    Yeh, Vince S. C.
    Kurukulasuriya, Ravi
    Fung, Steven
    Monzon, Katina
    Chiou, William
    Wang, Jiahong
    Stolarik, Deanne
    Imade, Hovis
    Shapiro, Robin
    Knourek-Segel, Victoria
    Bush, Eugene
    Wilcox, Denise
    Nguyen, Phong T.
    Brune, Michael
    Jacobson, Peer
    Link, J. T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5555 - 5560
  • [22] The synthesis and SAR of novel diarylsulfone 11β-HSD1 inhibitors
    Yan, Xuelei
    Wang, Zhulun
    Sudom, Athena
    Cardozo, Mario
    DeGraffenreid, Michael
    Di, Yongmei
    Fan, Pingchen
    He, Xiao
    Jaen, Juan C.
    Labelle, Marc
    Liu, Jinsong
    Ma, Ji
    McMinn, Dustin
    Miao, Shichang
    Sun, Daqing
    Tang, Liang
    Tu, Hua
    Ursu, Stefania
    Walker, Nigel
    Ye, Qiuping
    Powers, Jay P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 7071 - 7075
  • [23] Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1
    Tice, Colin M.
    Zhao, Wei
    Krosky, Paula M.
    Kruk, Barbara A.
    Berbaum, Jennifer
    Johnson, Judith A.
    Bukhtiyarov, Yuri
    Panemangalore, Reshma
    Scott, Boyd B.
    Zhao, Yi
    Bruno, Joseph G.
    Howard, Lamont
    Togias, Jennifer
    Ye, Yuan-Jie
    Singh, Suresh B.
    McKeever, Brian M.
    Lindblom, Peter R.
    Guo, Joan
    Guo, Rong
    Nar, Herbert
    Schuler-Metz, Annette
    Gregg, Richard E.
    Leftheris, Katerina
    Harrison, Richard K.
    McGeehan, Gerard M.
    Zhuang, Linghang
    Claremon, David A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6725 - 6729
  • [24] The discovery of azepane sulfonamides as potent 11β-HSD1 inhibitors
    Neelamkavil, Santhosh F.
    Boyle, Craig D.
    Chackalamannil, Samuel
    Greenlee, William J.
    Zhang, Lili
    Terracina, Giuseppe
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4563 - 4565
  • [25] Dammarane-type triterpenoids as 11β-HSD1 inhibitors from Homonoia riparia
    Yu, Jin-Hai
    Shen, Yu
    Liu, Hong-Bing
    Leng, Ying
    Zhang, Hua
    Yue, Jian-Min
    Organic and Biomolecular Chemistry, 2014, 12 (26): : 4716 - 4722
  • [26] Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)
    Sun, Daqing
    Wang, Zhulun
    Cardozo, Mario
    Choi, Rebekah
    DeGraffenreid, Michael
    Di, Yongmei
    He, Xiao
    Jaen, Juan C.
    Labelle, Marc
    Liu, Jinsong
    Ma, Ji
    Miao, Shichang
    Sudom, Athena
    Tang, Liang
    Tu, Hua
    Ursu, Stefania
    Walker, Nigel
    Yan, Xuelei
    Ye, Qiuping
    Powers, Jay P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (05) : 1522 - 1527
  • [27] Adamantane sulfone and sulfonamide 11-β-HSD1 Inhibitors
    Sorensen, Bryan
    Winn, Martin
    Rohde, Jeff
    Shuai, Qi
    Wang, Jiahong
    Fung, Steven
    Monzon, Katina
    Chiou, William
    Stolarik, DeAnne
    Imade, Hovis
    Pan, Liping
    Deng, Xiaoqing
    Chovan, Linda
    Longenecker, Kenton
    Judge, Russell
    Qin, Wenying
    Brune, Michael
    Camp, Heidi
    Frevert, Ernst U.
    Jacobson, Peer
    Link, J. T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (02) : 527 - 532
  • [28] Discovery of pyridyl sulfonamide 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors for the treatment of metabolic disorders
    Yoon, David S.
    Wu, Shung C.
    Seethala, Ramakrishna
    Golla, Rajasree
    Nayeem, Akbar
    Everlof, John G.
    Gordon, David A.
    Hamann, Lawrence G.
    Robl, Jeffrey A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (21) : 5045 - 5049
  • [29] Synthesis and biological evaluation of picolinamides as potent inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)
    Ryu, Je Ho
    Kim, Shinae
    Han, Hye Young
    Son, Hyun Joo
    Lee, Hyun Jung
    Shin, Young Ah
    Kim, Jae-Sun
    Park, Hyeung-geun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (03) : 695 - 700
  • [30] 11β-HSD1 Mediates Insulin Resistance and Type 2 Diabetes Mellitus through JNK Activation
    Peng, Kesong
    Liang, Guang
    FASEB JOURNAL, 2015, 29
12345